Onconova Therapeutics (ONTX) Widens Q2 Loss Amid Stronger Revs
Tweet Send to a Friend
Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($5.21) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
